Core Laboratories (CLB) Earnings Analysis

Core Laboratories (CLB) next reports earnings on 2026-07-29, consensus EPS 0.08 USD. Last quarter (2026-04-29) it beat with EPS 0.06 USD vs 0.06 USD est (0%). It has beaten estimates in 6/7 recent quarters (86%). Trailing P/E 18.40.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does CLB next report earnings?

Next earnings date2026-07-29
Consensus EPS estimate0.08 USD
Revenue estimate0.13B

CLB earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-290.06 USD0.06 USD0%Beat
2026-02-040.21 USD0.1912 USD+9.8%Beat
2025-10-220.22 USD0.19 USD+15.8%Beat
2025-07-230.19 USD0.18 USD+5.6%Beat
2025-01-290.22 USD0.23 USD-4.3%Miss
2024-10-230.25 USD0.23 USD+8.7%Beat
2024-07-240.22 USD0.21 USD+4.8%Beat

Beat rate: 6/7 (86%) over reported quarters with consensus data.

CLB valuation and analyst view

Trailing P/E18.40
Trailing EPS0.63017 USD
Price / book2.05
Dividend yield0.33%
Market cap0.55B
Analyst consensusHold (16 buy / 17 hold / 4 sell)

Related research pages

Frequently asked questions

When is Core Laboratories (CLB)'s next earnings date?

Core Laboratories is next scheduled to report on 2026-07-29, with a consensus EPS estimate of 0.08 USD and revenue estimate of 0.13B.

Did CLB beat earnings last quarter?

In its 2026-04-29 report, CLB posted EPS of 0.06 USD versus a 0.06 USD estimate — a beat of 0%.

What is CLB's earnings track record?

Over the last 7 reported quarters with consensus data, CLB beat estimates 6 times (86%).

What is CLB's current P/E ratio and EPS?

CLB trades at a trailing P/E of 18.40 on trailing EPS of 0.6301738545351941 USD.

What do analysts rate CLB?

Analyst consensus is "Hold" across 37 ratings (0 strong buy, 16 buy, 17 hold, 4 sell, 0 strong sell).